Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Futó vizsgálatok

• Még nem toboroz

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· 3. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Még nem toboroz

  A Study of Ivonescimab Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC

  2026-526300-67-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Még nem toboroz

  Low-dose cyclophosphamide maintenance after neoadjuvant systemic chemotherapy and surgery to eradicate microscopic residual disease in PDAC

  2026-526296-28-00· 3. fázis· Associazione Italiana Per Lo Studio Del Pancreas· Forrás

• Még nem toboroz

  A Phase 3 Open-Label, Randomized Controlled Trial of T-bren (BL-M07D1) vs. Platinum-based Chemotherapy in Patients with HER2-expressing metastatic urothelial cancer with disease progression on or after anti-PD-(L)1-based therapy

  2026-527617-29-00· 3. fázis· Systimmune Inc.· Forrás

• Még nem toboroz

  Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units

  NCT07418164· IRCCS San Raffaele· Forrás

• Még nem toboroz

  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás

• Toboroz

  Artificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study

  NCT07664748· Niguarda Hospital· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).

  2026-526139-20-00· 3. fázis· Kardigan Inc.· Forrás

• Toboroz

  A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer

  2025-524080-20-00· 1. fázis· Novartis Pharma AG· Forrás

• Toboroz

  PSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer

  NCT07879820· Niguarda Hospital· Forrás

• Még nem toboroz

  Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study"

  NCT07746232· Fondazione EMN Italy Onlus· Forrás

• Még nem toboroz

  DYNAMIC ” IDentifY the best therapeutic sequeNcing strAtegy in oncogene addICted NSCLC:” “A multi-arms prospective, randomized phase II study to evaluate the best sequential therapeutic strategis in patients with metastatic non-small cell lung cancer harboring targetable genomic driver alterations”

  2026-525268-16-00· 2/3. fázis· Universita' Degli Studi Di Torino· Forrás

• Toboroz

  A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum

  NCT07811193· 2. fázis· Vividion Therapeutics, Inc.· Forrás

• Még nem toboroz

  Neurocognitive Assessment in Long-Term Survivors of Lymphoma

  NCT07652476· Fondazione Italiana Linfomi - ETS· Forrás

• Még nem toboroz

  triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

  NCT07440381· 3. fázis· Heart Care Foundation· Forrás

• Toboroz

  Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

  NCT07247162· 4. fázis· RECORDATI GROUP· Forrás

• Toboroz

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· 3. fázis· Kardigan, Inc.· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy

  NCT07424677· 3. fázis· Zydus Therapeutics Inc.· Forrás

• Toboroz

  PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma

  NCT07256158· 3. fázis· Fondazione Italiana Linfomi - ETS· Forrás

• Fut, nem toboroz

  A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small cell lung cancer.

  2023-503298-39-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease

  2025-524001-33-00· 2. fázis· Immunovant Sciences GmbH· Forrás

• Fut, nem toboroz

  Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

  NCT07468071· 1/2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· 3. fázis· Immuneering Corporation· Forrás

• Toboroz

  Study carried out at multiple centers to test Glofitamab in patients with mantle cell lymphoma who did not respond well to, or relapsed after, CAR T-cell therapy.

  2025-523428-39-00· 2. fázis· Fondazione Italiana Linfomi Ets· Forrás

• Toboroz

  Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

  NCT07453095· 2. fázis· Fondazione Italiana Linfomi - ETS· Forrás

• Toboroz

  MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without Obinutuzumab

  NCT07024706· 2. fázis· AstraZeneca· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Toboroz

  A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  NCT07192952· 3. fázis· Bayer· Forrás

• Toboroz

  Study of GVV858 as a single agent or in combination with endocrine therapy in patients with HR+/HER2- breast cancer and other advanced solid tumors

  2025-521911-38-00· 1/2. fázis· Novartis Pharma AG· Forrás

• Toboroz

  BIO|STREAM.CSP Study

  NCT07393009· Biotronik SE & Co. KG· Forrás

• Toboroz

  INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

  NCT07429266· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

  NCT07413939· 2/3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A phase 2, multicentric study to assess the efficacy and safety of maribavir treatment in hematopoietic stem cell transplant (HSCT) recipients with cytomegalovirus (CMV) infection with a medical condition that contraindicate the administration of ganciclovir, valganciclovir or foscarnet and in those who discontinued first line preemptive therapy with ganciclovir, valganciclovir or foscarnet due to toxicity or intolerance.

  2025-521074-34-00· 2. fázis· Gruppo Italiano Per Il Trapianto Di Midollo Osseo Cellule Staminali Emopoietiche E Terapia Cellulare· Forrás

• Toboroz

  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  NCT07549412· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

  NCT07342478· 3. fázis· Newave Pharmaceutical Inc· Forrás

• Fut, nem toboroz

  AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  NCT07533175· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study

  2025-522338-30-00· 2. fázis· Eli Lilly & Co.· Forrás

• Toboroz

  Bilateral Versus Unilateral Lymph Node Dissection in High-Risk Prostate Cancer (BALANCE)

  NCT07580196· University of Turin, Italy· Forrás

• Toboroz

  Zanubritnib and anti-MAG neuropathy

  NCT07392229· 2. fázis· Azienda Ospedaliera di Padova· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07351058· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"

  NCT07381764· 2. fázis· Gruppo Oncologico Italia Meridionale· Forrás

• Toboroz

  Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

  NCT07219459· 2. fázis· CatalYm GmbH· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

  NCT07282574· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  NCT07284849· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  NCT07223814· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy.

  2025-522553-19-00· 2/3. fázis· Kardigan Inc.· Forrás

• Toboroz

  A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07210723· 2/3. fázis· Kardigan, Inc.· Forrás

• Toboroz

  Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  NCT07431281· 3. fázis· AstraZeneca· Forrás

Showing 50 of 324.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák32 toboroz
• Tüdőrák28 toboroz
• Krónikus limfoid leukémia (CLL)16 toboroz
• Szívelégtelenség12 toboroz
• Hasnyálmirigyrák11 toboroz
• Máj- és epeúti rák11 toboroz
• Akut mieloid leukémia (AML)10 toboroz
• Gyomor- és nyelőcsőrák10 toboroz
• Gyermekkori daganatok9 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)6 toboroz
• Follikuláris limfóma6 toboroz
• Mieloproliferatív neopláziák6 toboroz
• Méhtestrák5 toboroz
• Mielodiszplasztikus szindróma (MDS)5 toboroz
• Petefészekrák5 toboroz
• Pitvarfibrilláció5 toboroz
• Prosztatarák5 toboroz
• Stroke (szélütés)5 toboroz
• 2-es típusú cukorbetegség4 toboroz
• Áttétes emlőrák4 toboroz
• Dilated cardiomyopathy4 toboroz
• Fej-nyaki daganatok4 toboroz
• Immune thrombocytopenia (ITP)4 toboroz
• Liver cirrhosis4 toboroz
• Hodgkin-limfóma3 toboroz
• Köpenysejtes limfóma3 toboroz
• Koszorúér-betegség3 toboroz
• Magas vérnyomás3 toboroz
• Mielóma multiplex3 toboroz
• Myocarditis3 toboroz
• Primer biliáris cholangitis (PBC)3 toboroz
• Colitis ulcerosa2 toboroz
• Cushing's syndrome2 toboroz
• Elhízás2 toboroz
• Hipertrófiás kardiomiopátia2 toboroz
• Hólyagrák2 toboroz
• Krónikus mieloid leukémia (CML)2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Amiloidózis1 toboroz
• Aortic stenosis1 toboroz
• Arthritis psoriatica1 toboroz
• Cytomegalovirus infection1 toboroz
• Duchenne-izomdisztrófia1 toboroz
• Fabry-betegség1 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Graves' disease and hyperthyroidism1 toboroz
• HIV-fertőzés1 toboroz
• IgA-nefropátia1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Méhnyakrák1 toboroz
• Melanóma1 toboroz
• Osteoarthritis1 toboroz
• Peripheral artery disease1 toboroz
• Pikkelysömör1 toboroz
• Rheumatoid arthritis1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Thalassaemia1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vesedaganat1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC

  2025-522867-13-00· 2. fázis· Merus B.V.· Forrás

• Lezárult

  A trial to learn how safe saruparib is and how well it works in people with advanced ovarian cancer

  2024-519044-32-00· 1/2. fázis· AstraZeneca AB· Forrás

• Lezárult

  AUSTRAL trial: An open-label, multicenter, phase II study of radiotherapy followed by durvalumab (MEDI4736) and ceralasertib (AZD6738) in stage III NSCLC patients with thoracic relapses +/- oligometastases after PACIFIC regimen

  2024-515942-18-01· 2. fázis· Istituto Di Ricerche Farmacologiche Mario Negri· Forrás

• Lezárult

  A Study to see How Well and How Safely Different Treatments Work in a Group of Patients with Non-Small Cell Lung Cancer, Chosen Based on their Biomarker Status

  2024-511239-91-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás

• Visszavonták

  Melflufen for Elderly Patients With Relapsed Myeloma

  NCT06682637· 2. fázis· Fondazione EMN Italy Onlus· Forrás

• Lezárult

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

  NCT06664801· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

  NCT06261957· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis

  2023-504564-42-00· 2. fázis· Anaptysbio Inc.· Forrás

• Lezárult

  FIH study of ALE.C04 anti-CLDN1 mAb monotherapy or in combination with pembrolizumab in patients with R/M HNSCC

  2023-505145-93-00· 1/2. fázis· Alentis Therapeutics AG· Forrás

• Lezárult

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  Phase II study evaluating Holmium-166 TARE followed by maIntenance Therapy in liver limited unresectable colorectal cancer patients after first-lIne chemotherapy and target agents: The HAITI study.

  2023-505356-22-00· 2. fázis· Gruppo Oncologico Del Nord Ovest· Forrás

• Lezárult

  A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy

  NCT06058741· AbbVie· Forrás

• Lezárult

  A Phase 3 Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)

  2023-509472-42-00· 3. fázis· Celgene International II S.a.r.l.· Forrás

• Lezárult

  A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)

  NCT06269107· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

  NCT06214052· 2. fázis· ViiV Healthcare· Forrás

• Lezárult

  A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia with or without NPM1 Mutation (RIVER-52)

  2023-505910-10-00· 2. fázis· Ryvu Therapeutics S.A.· Forrás

• Leállították

  Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

  NCT06268574· 2. fázis· Ryvu Therapeutics SA· Forrás

• Visszavonták

  R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

  NCT05966233· 2. fázis· Fondazione Italiana Linfomi - ETS· Forrás

• Lezárult

  Study of BMS-986466 with Adagrasib with or without Cetuximab in Participants with KRAS G12C-mutant Solid Tumors

  NCT06024174· 1/2. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Lezárult

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Novo Nordisk A/S· Forrás

• Lezárult

  Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

  NCT06153693· 3. fázis· Mineralys Therapeutics Inc.· Forrás

• Lezárult

  Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy

  2022-502316-36-00· 4. fázis· Myokardia Inc.· Forrás

• Fut, nem toboroz

  Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT06122779· 2. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  A Phase 1b/2 Study of BMS-986442 with Nivolumab with or without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

  2022-503108-26-00· 1/2. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Leállították

  A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

  NCT06032546· 2. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Lezárult

  Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  2022-502196-31-00· 2/3. fázis· Kartos Therapeutics Inc.· Forrás

• Lezárult

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

  NCT05952856· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

  2022-502267-37-00· 1/2. fázis· K-Group Beta Inc.· Forrás

• Fut, nem toboroz

  Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

  NCT05968430· 3. fázis· Mineralys Therapeutics Inc.· Forrás

• Leállították

  Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®

  NCT05900050· 2. fázis· Genfit· Forrás

• Lezárult

  RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)

  NCT06935578· Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta· Forrás

• Leállították

  A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

  NCT05678257· 2. fázis· NuCana plc· Forrás

• Lezárult

  A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

  NCT07304843· 1/2. fázis· Umecrine Cognition AB· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Contrast-Associated Nephropathy Risk Evaluation in Acute Ischemic Stroke After Endovascular Thrombectomy

  NCT06596603· Niguarda Hospital· Forrás

• Leállították

  ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

  NCT05743036· 1. fázis· K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc· Forrás

• Lezárult

  Relatlimab + Nivolumab in Pediatric and Young Adult Lymphomas (RELATIVITY-069)

  2023-503715-14-00· 1/2. fázis· Bristol Myers Squibb International Corporation· Forrás

• Lezárult

  Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

  NCT05630807· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Study of Relatlimab-nivolumab Fixed-dose Combination versus Regorafenib or TAS-102 in Participants with Later-lines of Metastatic Colorectal Cancer

  NCT05328908· 3. fázis· Bristol Myers Squibb International Corporation· Forrás

• Fut, nem toboroz

  Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

  NCT05349214· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

  NCT05263934· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

  NCT05387811· Azienda Ospedaliera di Padova· Forrás

• Lezárult

  A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)

  NCT05546905· Pierre Fabre Medicament· Forrás

• Lezárult

  An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers

  2023-508954-25-00· 1/2. fázis· Bristol Myers Squibb International Corporation· Forrás

• Leállították

  A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

  NCT05161481· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

  NCT05206513· 3. fázis· Neurocrine Biosciences· Forrás

• Lezárult

  Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

  NCT05156320· 3. fázis· Scholar Rock, Inc.· Forrás

• Lezárult

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· 3. fázis· Amgen· Forrás

• Lezárult

  GliflOzin in eLderly Diabetic patiENts: A praGmatic intraclass Evaluation trial

  2024-518915-20-00· 4. fázis· Center For Outcomes Research And Clinical Epidemiology S.r.l.· Forrás

Showing 50 of 119.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Szívelégtelenség103 munka · 18 vizsgálat
• Epilepszia35 munka · 1 vizsgálat
• Myocarditis29 munka · 3 vizsgálat
• Krónikus limfoid leukémia (CLL)17 munka · 36 vizsgálat
• Primer biliáris cholangitis (PBC)14 munka · 6 vizsgálat
• Ventricular tachycardia14 munka · 0 vizsgálat
• Amiloidózis12 munka · 1 vizsgálat
• Köpenysejtes limfóma8 munka · 15 vizsgálat
• Brain aneurysm8 munka · 2 vizsgálat
• Cushing's syndrome7 munka · 2 vizsgálat
• Sarcoidosis7 munka · 0 vizsgálat
• Immune thrombocytopenia (ITP)5 munka · 5 vizsgálat
• Spinális izomatrófia (SMA)5 munka · 2 vizsgálat
• Duchenne-izomdisztrófia5 munka · 2 vizsgálat